When comparing the endocrinologist to IM cohorts (43,693 vs. 43,693), the endocrinologist cohort also had significantly higher frequency of all types of testing, prescription of insulin (0.4 times/month), and diabetes-related costs (USD 430 more) (Table 3). The gene discussed is INS; the disease is diabetes mellitus.